Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-16
DOI
10.1007/s00262-022-03182-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
- (2021) Jinah Yeo et al. Pharmaceuticals
- An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
- (2021) Paula Voabil et al. NATURE MEDICINE
- CD96 functions as a co‐stimulatory receptor to enhance CD8 + T cell activation and effector responses
- (2020) Eugene Y. Chiang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A phase II multi-arm study of durvalumab and tremelimumab for advanced or metastatic sarcomas.
- (2020) Neeta Somaiah et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- TIGIT enhances CD4 + regulatory T‐cell response and mediates immune suppression in a murine ovarian cancer model
- (2020) Fengzhen Chen et al. Cancer Medicine
- A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
- (2020) Junbin Qian et al. CELL RESEARCH
- Immunodynamics of explanted human tumors for immuno‐oncology
- (2020) Agathe Dubuisson et al. EMBO Molecular Medicine
- Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer
- (2019) Lukas W. Pfannenstiel et al. Cancer Immunology Research
- Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
- (2019) Brian C. Miller et al. NATURE IMMUNOLOGY
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
- (2019) Mathieu Grapin et al. Journal for ImmunoTherapy of Cancer
- Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study
- (2019) Cynthia Reichling et al. GUT
- Tumor‑infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases
- (2019) Katarzyna Jakubowska et al. Experimental and Therapeutic Medicine
- TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma
- (2018) Camille Guillerey et al. BLOOD
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
- (2018) Alice L. Hung et al. OncoImmunology
- The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
- (2018) Marc Van den Eynde et al. CANCER CELL
- Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
- (2018) Xiu-Man Zhou et al. Frontiers in Immunology
- TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
- (2017) Nicholas A. Manieri et al. TRENDS IN IMMUNOLOGY
- PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells
- (2017) Rajeev Kumar et al. OncoTargets and Therapy
- CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
- (2017) Peter W. Eide et al. Scientific Reports
- T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
- (2016) Y. Kong et al. CLINICAL CANCER RESEARCH
- Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
- (2016) S. J. Blake et al. Cancer Discovery
- TCGA2STAT: simple TCGA data access for integrated statistical analysis in R
- (2015) Ying-Wooi Wan et al. BIOINFORMATICS
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Phenotype and Function of T Cells Infiltrating Visceral Metastases from Gastrointestinal Cancers and Melanoma: Implications for Adoptive Cell Transfer Therapy
- (2013) S. Turcotte et al. JOURNAL OF IMMUNOLOGY
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration
- (2013) Niels Halama et al. OncoImmunology
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
- (2009) N. Stanietsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD96 Interaction with CD155 via Its First Ig-like Domain Is Modulated by Alternative Splicing or Mutations in Distal Ig-like Domains
- (2008) Dorothee Meyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started